カリフォルニア州における腎臓がんの臨床試験
カリフォルニア州内の拠点で、腎臓がんに関する19件の研究が参加者を募集しています。
カリフォルニア州内の都市
- San Diego9件の研究
- Los Angeles7件の研究
- Baldwin Park6件の研究
- Mountain View6件の研究
- San Francisco4件の研究
- Orange4件の研究
- Irvine3件の研究
- Sacramento3件の研究
公式研究テキスト（英語）
Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 他10件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of California San Diego Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- University of California Irvine, Orange
- Stanford, Palo Alto
- University of California San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05287945Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07011719Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- City of Hope Investigational Drug Services (IDS), Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- 他13件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, San Diego
- Research Site, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Los Angeles Site, Duarte
- NEO-811 San Diego Site, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Duarte
- Xencor Investigative Site, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06580002KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- University of Southern California, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410A Study of VET3-TGI in Patients With Solid Tumors
- USC/Norris Comprehensive Cancer Center, Los Angeles
- UC Irvine Health, Orange
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/07更新 · NCT0644481564Cu-GRIP B in Patients With Advanced Malignancies
- University of California, San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/17更新 · NCT05888532cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- VA Palo Alto Healthcare System, Palo Alto
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/26更新 · NCT07303725SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- UCSD Moores Cancer Center, La Jolla
- UCLA Medical Center, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
- Institute of Urology, University of Southern California., Los Angeles
- University of California San Diego, Moores Cancer Center, San Diego
- Stanford University, Stanford
被験者募集中観察研究
18歳以上 · 全性別 · 2022/05/06更新 · NCT05363657ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。